2017 Annual Responsibility Review

Primary tabs

2017 Annual Responsibility Review

Shire’s new Responsibility strategy includes ambitious long-term goals to be achieved by 2025, aimed at further enhancing the Company’s commitment to Responsibility and positively impacting patients, our employees, and our communities.

Supporting patients: We are committed to shortening the time to diagnosis for patients living with rare diseases. We aim to support patients and their families along their entire journey, including involvement in clinical trials and managing their care with innovative digital technologies.

People and culture: Equipping our employees for success is vital to serving our patients and communities. This includes providing a sense of purpose to what we do every day in a safe and inclusive environment that treats all people equally and fairly.

Sustainable operations: Managing sustainable operations means sourcing and manufacturing responsibly, delivering safe and effective medicines, and using natural resources carefully. This helps ensure our patients receive the treatments they need to lead healthier lives.

Additional information about Responsibility at Shire can also be found in Shire’s 2017 Annual Report, available at http://investors.shire.com/presentations-and-reports/ar-2017.aspx

Content from this campaign

Shire Commits to Long-term Responsibility Goals in 2017 Annual Responsibility Review
CAMBRIDGE, Mass., March 22, 2018 /3BL Media/ – Shire plc (LSE: SHP, NASDAQ: SHPG) today announced the release of the Company’s 2017 Annual Responsibility Review. The Review, available at shire.com/responsibility outlines Shire’s new Responsibility strategy that includes ambitious long-term goals to be achieved by 2025, aimed at...
Mar 22, 2018 11:00 AM ET